[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100537183":3},{"organization":4,"outcomesModule":7,"designInfo":32,"detailedDescription":11,"studyPopulation":11,"armGroups":38,"interventions":49,"overallOfficials":55,"centralContacts":59,"locations":67,"responsibleParty":334,"collaborators":11,"id":336,"slug":337,"hasResults":338,"nctId":339,"briefTitle":340,"officialTitle":341,"acronym":342,"eligibilityCriteria":343,"healthyVolunteers":338,"sex":344,"minAge":345,"maxAge":11,"enrollmentInfo":346,"targetDuration":11,"studyType":349,"phases":350,"briefSummary":352,"conditions":353,"keywords":11,"overallStatus":70,"whyStopped":11,"lastUpdateSubmitDate":355,"lastUpdatePostDateStruct":356,"startDateStruct":359,"completionDateStruct":361,"leadSponsor":363,"locationsCount":364},{"fullName":5,"class":6},"Hoffmann-La Roche","INDUSTRY",{"primaryOutcomes":8,"secondaryOutcomes":11,"otherOutcomes":11},[9,13,15,17,20,22,24,26,28,30],{"measure":10,"description":11,"timeFrame":12},"Changes from baseline in HER2 protein levels measured at the time of disease progression\u002Frecurrence (Cohorts H1 and H2)",null,"At least 6 months",{"measure":14,"description":11,"timeFrame":12},"Changes from baseline in HER2 gene copy number measured at the time of disease progression\u002Frecurrence (Cohorts H1 and H2)",{"measure":16,"description":11,"timeFrame":12},"Changes from baseline in estrogen receptor (ER) protein levels measured at the time of disease progression\u002Frecurrence (Cohorts H1 and H2)",{"measure":18,"description":11,"timeFrame":19},"Changes from baseline in HER2 protein levels measured at the time of disease progression\u002Frecurrence (Cohort H3)","Less than 6 months",{"measure":21,"description":11,"timeFrame":19},"Changes from baseline in HER2 gene copy number measured at the time of disease progression\u002Frecurrence (Cohort H3)",{"measure":23,"description":11,"timeFrame":19},"Changes from baseline in ER protein levels measured at the time of disease progression\u002Frecurrence (Cohort H3)",{"measure":25,"description":11,"timeFrame":12},"Changes from baseline in genes related to CDK4\u002F6 resistance (incl. cell cycle alterations and tyrosine kinase receptors, Cohort R1)",{"measure":27,"description":11,"timeFrame":12},"Changes from baseline in genes related to endocrine resistance (incl. cell cycle alterations and tyrosine kinase receptors, Cohort R1)",{"measure":29,"description":11,"timeFrame":12},"Changes from baseline in tumor immune microenvironment (PD-L1 and TILs, Cohort T1)",{"measure":31,"description":11,"timeFrame":12},"Changes from baseline in immune phenotype (PD-L1 and TILs, Cohort T1)",{"allocation":33,"interventionModel":34,"interventionModelDescription":11,"primaryPurpose":35,"observationalModel":11,"timePerspective":11,"maskingInfo":36},"NON_RANDOMIZED","PARALLEL","TREATMENT",{"masking":37,"maskingDescription":11,"whoMasked":11},"NONE",[39,45],{"label":40,"type":41,"description":42,"interventionNames":43},"Mechanisms of Acquired Resistance","EXPERIMENTAL","Participants with breast cancer who have a newly appearing or recurrent metastatic lesion while on anti-cancer therapy will be assigned to one of 3 cohorts.",[44],"Procedure: Tumor Tissue and Blood Draw",{"label":46,"type":41,"description":47,"interventionNames":48},"Mechanisms of Primary Resistance","Participants with breast cancer who have a progressing tumor lesion while on anti-cancer therapy will be assigned to one of 2 cohorts.",[44],[50],{"type":51,"name":52,"description":53,"armGroupLabels":54,"otherNames":11},"PROCEDURE","Tumor Tissue and Blood Draw","Participants will have their blood drawn on the day a tissue sample is taken from a progressive tumor lesion.",[40,46],[56],{"name":57,"affiliation":5,"role":58},"Clinical Trials","STUDY_DIRECTOR",[60,65],{"name":61,"role":62,"phone":63,"phoneExt":11,"email":64},"Reference Study ID Number: WO44977 https:\u002F\u002Fforpatients.roche.com\u002F No attachments to email below.","CONTACT","888-662-6728 (U.S. Only)","global-roche-genentech-trials@gene.com",{"name":66,"role":62,"phone":11,"phoneExt":11,"email":11},"Fastest response: use the inquiry form. https:\u002F\u002Fwww.gene.com\u002Fcontact-us\u002Fsubmit-medical-inquiry",[68,81,90,99,108,119,128,139,148,159,168,177,186,195,207,216,226,236,246,252,258,270,281,287,296,305,316,325],{"facility":69,"status":70,"city":71,"state":11,"zip":72,"country":73,"countryCode":74,"cosmosGeoPoint":75,"geoPoint":80,"contacts":11},"Institut Jules Bordet","RECRUITING","Anderlecht","1070","Belgium","BE",{"type":76,"coordinates":77},"Point",[78,79],4.31454,50.83619,{"lat":79,"lon":78},{"facility":82,"status":70,"city":83,"state":11,"zip":84,"country":73,"countryCode":74,"cosmosGeoPoint":85,"geoPoint":89,"contacts":11},"AZ KLINA","Brasschaat","2930",{"type":76,"coordinates":86},[87,88],4.49182,51.2912,{"lat":88,"lon":87},{"facility":91,"status":70,"city":92,"state":11,"zip":93,"country":73,"countryCode":74,"cosmosGeoPoint":94,"geoPoint":98,"contacts":11},"CHU de Liège (Sart Tilman)","Liège","4000",{"type":76,"coordinates":95},[96,97],5.56749,50.63373,{"lat":97,"lon":96},{"facility":100,"status":70,"city":101,"state":11,"zip":102,"country":73,"countryCode":74,"cosmosGeoPoint":103,"geoPoint":107,"contacts":11},"AZ Delta (Campus Rumbeke)","Roeselare","8800",{"type":76,"coordinates":104},[105,106],3.12269,50.94653,{"lat":106,"lon":105},{"facility":109,"status":70,"city":110,"state":11,"zip":111,"country":112,"countryCode":113,"cosmosGeoPoint":114,"geoPoint":118,"contacts":11},"Aalborg Universitetshospital","Aalborg","9000","Denmark","DK",{"type":76,"coordinates":115},[116,117],9.9187,57.048,{"lat":117,"lon":116},{"facility":120,"status":70,"city":121,"state":11,"zip":122,"country":112,"countryCode":113,"cosmosGeoPoint":123,"geoPoint":127,"contacts":11},"Sjællands Universitetshospital, Næstved","Næstved","4700",{"type":76,"coordinates":124},[125,126],11.76092,55.22992,{"lat":126,"lon":125},{"facility":129,"status":70,"city":130,"state":11,"zip":131,"country":132,"countryCode":133,"cosmosGeoPoint":134,"geoPoint":138,"contacts":11},"Helsinki University Central Hospital","Helsinki","00029","Finland","FI",{"type":76,"coordinates":135},[136,137],24.93545,60.16952,{"lat":137,"lon":136},{"facility":140,"status":70,"city":141,"state":11,"zip":142,"country":132,"countryCode":133,"cosmosGeoPoint":143,"geoPoint":147,"contacts":11},"Tampere University Hospital","Tampere","33520",{"type":76,"coordinates":144},[145,146],23.78712,61.49911,{"lat":146,"lon":145},{"facility":149,"status":70,"city":150,"state":11,"zip":151,"country":152,"countryCode":153,"cosmosGeoPoint":154,"geoPoint":158,"contacts":11},"St. Elisabeth Krankenhaus Köln GmbH","Cologne","50935","Germany","DE",{"type":76,"coordinates":155},[156,157],6.95,50.93333,{"lat":157,"lon":156},{"facility":160,"status":70,"city":161,"state":11,"zip":162,"country":152,"countryCode":153,"cosmosGeoPoint":163,"geoPoint":167,"contacts":11},"KEM\u002FEvang. Kliniken Essen Mitte gGmbH","Essen","45136",{"type":76,"coordinates":164},[165,166],7.01228,51.45657,{"lat":166,"lon":165},{"facility":169,"status":70,"city":170,"state":11,"zip":171,"country":152,"countryCode":153,"cosmosGeoPoint":172,"geoPoint":176,"contacts":11},"ViDia Christliche Kliniken Karlsruhe, Vincentius-Diakonissen-Kliniken gAG","Karlsruhe","76135",{"type":76,"coordinates":173},[174,175],8.40444,49.00937,{"lat":175,"lon":174},{"facility":178,"status":70,"city":179,"state":11,"zip":180,"country":152,"countryCode":153,"cosmosGeoPoint":181,"geoPoint":185,"contacts":11},"Universitätsklinikum Mannheim","Mannheim","68167",{"type":76,"coordinates":182},[183,184],8.46694,49.4891,{"lat":184,"lon":183},{"facility":187,"status":70,"city":188,"state":11,"zip":189,"country":152,"countryCode":153,"cosmosGeoPoint":190,"geoPoint":194,"contacts":11},"Universitätsfrauenklinik Ulm","Ulm","89075",{"type":76,"coordinates":191},[192,193],9.99155,48.39841,{"lat":193,"lon":192},{"facility":196,"status":70,"city":197,"state":198,"zip":199,"country":200,"countryCode":201,"cosmosGeoPoint":202,"geoPoint":206,"contacts":11},"I.R.S.T Srl IRCCS","Meldola","Emilia-Romagna","47014","Italy","IT",{"type":76,"coordinates":203},[204,205],12.0626,44.12775,{"lat":205,"lon":204},{"facility":208,"status":70,"city":209,"state":198,"zip":210,"country":200,"countryCode":201,"cosmosGeoPoint":211,"geoPoint":215,"contacts":11},"Azienda Ospedaliero - Universitaria di Modena Policlinico","Modena","41110",{"type":76,"coordinates":212},[213,214],10.92539,44.64783,{"lat":214,"lon":213},{"facility":217,"status":70,"city":218,"state":219,"zip":220,"country":200,"countryCode":201,"cosmosGeoPoint":221,"geoPoint":225,"contacts":11},"RCCS - Centro di Riferimento","Aviano (PN)","Friuli Venezia Giulia","33081",{"type":76,"coordinates":222},[223,224],12.59472,46.07056,{"lat":224,"lon":223},{"facility":227,"status":70,"city":228,"state":229,"zip":230,"country":200,"countryCode":201,"cosmosGeoPoint":231,"geoPoint":235,"contacts":11},"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","Rome","Lazio","00168",{"type":76,"coordinates":232},[233,234],12.51133,41.89193,{"lat":234,"lon":233},{"facility":237,"status":70,"city":238,"state":239,"zip":240,"country":200,"countryCode":201,"cosmosGeoPoint":241,"geoPoint":245,"contacts":11},"Ospedale San Raffaele S.r.l. - PPDS","Milan","Lombardy","20132",{"type":76,"coordinates":242},[243,244],9.18951,45.46427,{"lat":244,"lon":243},{"facility":247,"status":70,"city":238,"state":239,"zip":248,"country":200,"countryCode":201,"cosmosGeoPoint":249,"geoPoint":251,"contacts":11},"Irccs Istituto Nazionale Dei Tumori (Int)","20133",{"type":76,"coordinates":250},[243,244],{"lat":244,"lon":243},{"facility":253,"status":70,"city":238,"state":239,"zip":254,"country":200,"countryCode":201,"cosmosGeoPoint":255,"geoPoint":257,"contacts":11},"Irccs Istituto Europeo Di Oncologia (IEO)","20141",{"type":76,"coordinates":256},[243,244],{"lat":244,"lon":243},{"facility":259,"status":260,"city":261,"state":11,"zip":262,"country":263,"countryCode":264,"cosmosGeoPoint":265,"geoPoint":269,"contacts":11},"Oslo university hospital Radiumhospitalet","WITHDRAWN","Oslo","0424","Norway","NO",{"type":76,"coordinates":266},[267,268],10.74609,59.91273,{"lat":268,"lon":267},{"facility":271,"status":70,"city":272,"state":11,"zip":273,"country":274,"countryCode":275,"cosmosGeoPoint":276,"geoPoint":280,"contacts":11},"Hospital Universitario 12 de Octubre","Madrid","28041","Spain","ES",{"type":76,"coordinates":277},[278,279],-3.70256,40.4165,{"lat":279,"lon":278},{"facility":282,"status":70,"city":272,"state":11,"zip":283,"country":274,"countryCode":275,"cosmosGeoPoint":284,"geoPoint":286,"contacts":11},"HM Sanchinarro ? CIOCC","28050",{"type":76,"coordinates":285},[278,279],{"lat":279,"lon":278},{"facility":288,"status":70,"city":289,"state":11,"zip":290,"country":274,"countryCode":275,"cosmosGeoPoint":291,"geoPoint":295,"contacts":11},"Hospital Universitario Virgen del Rocio","Seville","41013",{"type":76,"coordinates":292},[293,294],-5.97317,37.38283,{"lat":294,"lon":293},{"facility":297,"status":70,"city":298,"state":11,"zip":299,"country":274,"countryCode":275,"cosmosGeoPoint":300,"geoPoint":304,"contacts":11},"Hospital Clínico Universitario de Valencia","Valencia","46010",{"type":76,"coordinates":301},[302,303],-0.37966,39.47391,{"lat":303,"lon":302},{"facility":306,"status":70,"city":307,"state":11,"zip":308,"country":309,"countryCode":310,"cosmosGeoPoint":311,"geoPoint":315,"contacts":11},"Basingstoke and North Hampshire Hospital","Basingstoke","RG24 9NA","United Kingdom","UK",{"type":76,"coordinates":312},[313,314],-1.08708,51.26249,{"lat":314,"lon":313},{"facility":317,"status":70,"city":318,"state":11,"zip":319,"country":309,"countryCode":310,"cosmosGeoPoint":320,"geoPoint":324,"contacts":11},"Imperial College Healthcare NHS Trust","London","W6 8RF",{"type":76,"coordinates":321},[322,323],-0.12574,51.50853,{"lat":323,"lon":322},{"facility":326,"status":70,"city":327,"state":11,"zip":328,"country":309,"countryCode":310,"cosmosGeoPoint":329,"geoPoint":333,"contacts":11},"Christie Hospital NHS Trust","Manchester","M20 4BX",{"type":76,"coordinates":330},[331,332],-2.23743,53.48095,{"lat":332,"lon":331},{"type":335,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100537183","phase-4-a-study-to-investigate-mechanisms-of-resistance-to-breast-cancer-therapies-100537183",false,"NCT06274515","A Study to Investigate Mechanisms of Resistance to Breast Cancer Therapies","A Multi Cohort Translational Research Study to Investigate Mechanisms of Resistance to Breast Cancer Therapies","REMERGE","General Inclusion Criteria:\n\n* Willingness to undergo a procedure to obtain tumor tissue (e.g. biopsy) and blood draw\n* Diagnosis of HER2+, HR+ (for cohort R1) or triple negative breast cancer (for cohort T1) as per local assessment\n* Availability of an archival tumor tissue (most recent pre-treatment tumor tissue is preferred)\n* Unequivocally growing tumor lesion (progressive lesion) that is accessible for resection, excision or core needle biopsy\n* Discontinuation of prior anti-cancer treatment outlined below should not be longer than 4 weeks from participation in this study\n\nInclusion criteria for participants in the cohorts studying acquired resistance\n\n* Participant had undergone regular monitoring for disease progression as per local practice (preferably every 3-6 months) while on most recent breast cancer therapy\n* Accessible tumor lesion that newly appeared or a lesion that started to regrow while the participant was at least 6 months on therapy\n\nInclusion criteria for participants in the cohort studying primary resistance\n\n* Accessible tumor lesion that continued to increase in size or a newly appearing lesion (as confirmed by routine tumor assessment) while treated for at least 4 weeks but less than 6 months on therapy\n\nExclusion Criteria:\n\n* Any risks factors that increase the risk of complications associated with the procedure to obtain tumor tissue (e.g. bleeding disorders)\n* Any serious medical condition or abnormality in clinical laboratory tests that precludes an individual's safe participation in and completion of the study\n* Participant has started treatment with subsequent anti-cancer therapy\n* Participants whose progressive tumor lesion that is targeted for biopsy\u002Fresection is in the bone\n* Discontinuation of treatment was due to a reason other than disease progression","ALL","18 Years",{"count":347,"type":348},320,"ESTIMATED","INTERVENTIONAL",[351],"PHASE4","This study will evaluate mechanisms of resistance to anti-breast cancer therapies in tumor and blood samples from participants with human epidermal growth factor receptor (HER2) positive, hormone receptor (HR) positive or triple negative breast cancer.",[354],"Breast Cancer","2026-09-03",{"date":357,"type":358},"2026-09-04","ACTUAL",{"date":360,"type":358},"2024-04-02",{"date":362,"type":348},"2027-12-31",{"name":5,"class":6},28]